CA3129996C — Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
Assigned to Amarin Pharmaceuticals Ireland Ltd · Expires 2025-09-02 · 1y expired
What this patent protects
In various embodiments, the present invention provides eicosapentaenoate (EPA) compositions and methods for treating and/or preventing cardiovascular-related diseases in a subject in need thereof.
USPTO Abstract
In various embodiments, the present invention provides eicosapentaenoate (EPA) compositions and methods for treating and/or preventing cardiovascular-related diseases in a subject in need thereof.
Drugs covered by this patent
- Vascepa (ICOSAPENT ETHYL) · Amarin Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.